USFDA concludes inspection at Biocon's API manufacturing facility in Telangana

17 Dec 2018 Evaluate

US Food and Drug Administration (USFDA) has conducted a GMP inspection at Biocon's API manufacturing facility at Telangana from December 12 to 14, 2018. The inspection concluded without any observations and no Form 483 was issued. The successful inspection of this site reflects company's strong commitment to quality and cGMP compliance.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

370.20 4.95 (1.36%)
28-Jan-2026 15:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1609.85
Dr. Reddys Lab 1224.30
Cipla 1331.80
Zydus Lifesciences 895.00
Lupin 2132.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×